Best TWAS P=5.92e-17 · Best GWAS P=2.43e-17 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | C17orf65 | 0.07 | 0.06 | enet | 15 | 0.07 | 4.5e-09 | 7.21 | -7.3 | 2.7e-13 | -0.74 | 0.84 | 0.16 | FALSE |
2 | GTEx | Adipose Subcutaneous | ASB16-AS1 | 0.12 | 0.05 | enet | 16 | 0.05 | 3.7e-05 | 7.27 | -7.8 | 5.8e-15 | -0.64 | 0.21 | 0.47 | FALSE |
3 | GTEx | Adipose Visceral Omentum | ASB16-AS1 | 0.14 | 0.12 | lasso | 5 | 0.10 | 9.8e-06 | 7.28 | -7.4 | 1.1e-13 | -0.78 | 0.07 | 0.92 | FALSE |
4 | GTEx | Brain Cerebellum | ASB16-AS1 | 0.37 | 0.06 | enet | 32 | 0.19 | 3.1e-06 | 8.04 | -5.2 | 1.6e-07 | -0.68 | 0.03 | 0.86 | FALSE |
5 | GTEx | Brain Nucleus accumbens basal ganglia | ASB16-AS1 | 0.19 | 0.15 | enet | 16 | 0.13 | 2.0e-04 | 7.59 | -5.5 | 3.1e-08 | -0.62 | 0.04 | 0.67 | FALSE |
6 | GTEx | Breast Mammary Tissue | FZD2 | 0.35 | 0.01 | enet | 16 | 0.02 | 2.2e-02 | -1.33 | 5.3 | 1.4e-07 | 0.53 | 0.04 | 0.37 | FALSE |
7 | GTEx | Breast Mammary Tissue (Female) | ASB16-AS1 | 0.08 | 0.04 | lasso | 2 | 0.06 | 7.9e-03 | 7.28 | -7.3 | 3.8e-13 | -0.77 | 0.06 | 0.50 | FALSE |
8 | GTEx | Cells Transformed fibroblasts | NAGS | 0.07 | 0.00 | enet | 13 | 0.00 | 3.2e-01 | 7.65 | 6.1 | 1.1e-09 | 0.66 | 0.08 | 0.29 | FALSE |
9 | GTEx | Cells Transformed fibroblasts | ASB16 | 0.14 | 0.14 | lasso | 3 | 0.12 | 2.0e-09 | 7.26 | -7.3 | 3.4e-13 | -0.79 | 0.76 | 0.24 | FALSE |
10 | GTEx | Cells Transformed fibroblasts | FZD2 | 0.11 | 0.00 | enet | 21 | 0.04 | 1.0e-03 | 0.16 | 5.6 | 2.8e-08 | 0.45 | 0.08 | 0.36 | FALSE |
11 | GTEx | Cells Transformed fibroblasts | ASB16-AS1 | 0.17 | 0.17 | lasso | 4 | 0.16 | 2.3e-12 | 7.26 | -7.0 | 3.1e-12 | -0.78 | 0.97 | 0.03 | FALSE |
12 | GTEx | Esophagus Gastroesophageal Junction | ASB16-AS1 | 0.17 | 0.13 | lasso | 7 | 0.11 | 8.6e-05 | 5.84 | -6.2 | 4.3e-10 | -0.64 | 0.06 | 0.78 | FALSE |
13 | GTEx | Esophagus Mucosa | HDAC5 | 0.06 | 0.05 | lasso | 3 | 0.02 | 9.2e-03 | 8.47 | -8.4 | 5.9e-17 | -0.99 | 0.01 | 0.97 | TRUE |
14 | GTEx | Esophagus Mucosa | ASB16 | 0.10 | 0.10 | lasso | 4 | 0.08 | 8.2e-06 | 7.27 | -7.3 | 2.9e-13 | -0.80 | 0.08 | 0.91 | FALSE |
15 | GTEx | Esophagus Mucosa | ASB16-AS1 | 0.11 | 0.08 | enet | 16 | 0.07 | 3.7e-05 | 8.00 | -7.1 | 1.1e-12 | -0.89 | 0.03 | 0.97 | FALSE |
16 | GTEx | Esophagus Muscularis | NAGS | 0.11 | 0.03 | enet | 10 | 0.05 | 5.1e-04 | -2.53 | 5.9 | 4.7e-09 | 0.58 | 0.13 | 0.22 | FALSE |
17 | GTEx | Heart Left Ventricle | RP5-882C2.2 | 0.14 | 0.08 | lasso | 5 | 0.10 | 8.1e-06 | 3.93 | -5.4 | 7.8e-08 | -0.66 | 0.33 | 0.58 | FALSE |
18 | GTEx | Lung | ASB16 | 0.09 | 0.09 | enet | 15 | 0.07 | 3.4e-06 | 7.27 | -5.7 | 1.4e-08 | -0.74 | 0.34 | 0.66 | FALSE |
19 | GTEx | Muscle Skeletal | ASB16 | 0.07 | 0.06 | lasso | 3 | 0.06 | 2.9e-06 | 6.59 | 7.1 | 1.1e-12 | 0.74 | 0.50 | 0.48 | FALSE |
20 | GTEx | Nerve Tibial | ASB16 | 0.12 | 0.07 | lasso | 5 | 0.07 | 7.5e-06 | 7.21 | -7.3 | 2.7e-13 | -0.79 | 0.86 | 0.13 | FALSE |
21 | GTEx | Nerve Tibial | ASB16-AS1 | 0.17 | 0.15 | lasso | 5 | 0.16 | 1.4e-11 | 7.22 | -7.1 | 1.5e-12 | -0.79 | 0.96 | 0.04 | FALSE |
22 | GTEx | Pituitary | ASB16-AS1 | 0.19 | 0.17 | lasso | 4 | 0.22 | 3.8e-06 | 7.59 | -8.3 | 8.1e-17 | -0.91 | 0.06 | 0.86 | FALSE |
23 | GTEx | Prostate | RP5-882C2.2 | 0.17 | -0.01 | lasso | 7 | -0.01 | 5.9e-01 | 6.59 | -5.8 | 8.9e-09 | -0.55 | 0.04 | 0.13 | FALSE |
24 | GTEx | Skin Sun Exposed Lower leg | ASB16 | 0.11 | 0.03 | enet | 9 | 0.02 | 4.3e-03 | 7.29 | -5.5 | 3.3e-08 | -0.73 | 0.18 | 0.57 | FALSE |
25 | GTEx | Skin Sun Exposed Lower leg | ASB16-AS1 | 0.13 | 0.09 | lasso | 5 | 0.07 | 2.7e-06 | 7.29 | -7.4 | 1.2e-13 | -0.82 | 0.56 | 0.44 | FALSE |
26 | GTEx | Testis | ASB16-AS1 | 0.35 | 0.25 | lasso | 5 | 0.23 | 1.0e-10 | 7.22 | -7.2 | 6.2e-13 | -0.79 | 0.85 | 0.15 | FALSE |
27 | GTEx | Thyroid | RP5-882C2.2 | 0.10 | 0.07 | lasso | 3 | 0.07 | 2.9e-06 | 7.23 | -7.1 | 1.6e-12 | -0.72 | 0.58 | 0.29 | FALSE |
28 | GTEx | Thyroid | ASB16-AS1 | 0.14 | 0.06 | lasso | 2 | 0.04 | 5.4e-04 | 7.22 | -7.3 | 2.8e-13 | -0.79 | 0.12 | 0.80 | FALSE |
29 | GTEx | Whole Blood | ASB16 | 0.11 | 0.03 | enet | 24 | 0.03 | 6.3e-04 | 7.29 | -5.8 | 5.8e-09 | -0.65 | 0.08 | 0.74 | FALSE |
30 | GTEx | Whole Blood | ASB16-AS1 | 0.14 | 0.05 | lasso | 6 | 0.04 | 3.1e-04 | 7.22 | -7.3 | 3.6e-13 | -0.81 | 0.12 | 0.88 | FALSE |
31 | YFS | Blood | G6PC3 | 0.02 | 0.01 | bslmm | 350 | 0.02 | 3.0e-06 | 2.83 | 6.4 | 1.4e-10 | 0.59 | 0.80 | 0.09 | FALSE |
32 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | ASB16 | 0.03 | 0.01 | enet | 4 | 0.02 | 1.2e-02 | 7.29 | -6.6 | 3.6e-11 | -0.74 | 0.02 | 0.67 | FALSE |
33 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C17orf65 | 0.03 | 0.00 | blup | 37 | 0.01 | 2.3e-02 | 7.23 | -6.8 | 9.3e-12 | -0.74 | 0.02 | 0.84 | FALSE |
34 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C17orf65 | 0.02 | 0.01 | blup | 38 | 0.02 | 2.6e-04 | 6.95 | -6.7 | 2.3e-11 | -0.75 | 0.02 | 0.94 | FALSE |
35 | The Cancer Genome Atlas | Colon Adenocarcinoma | ASB16 | 0.05 | 0.06 | blup | 40 | 0.05 | 4.6e-04 | 6.95 | -7.4 | 1.3e-13 | -0.80 | 0.02 | 0.94 | FALSE |
36 | The Cancer Genome Atlas | Colon Adenocarcinoma | C17orf65 | 0.05 | 0.06 | blup | 38 | 0.05 | 4.2e-04 | 6.59 | -7.3 | 3.3e-13 | -0.78 | 0.02 | 0.95 | FALSE |
37 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | ASB16 | 0.02 | 0.02 | blup | 39 | 0.02 | 3.8e-03 | 7.19 | -6.4 | 1.5e-10 | -0.74 | 0.02 | 0.46 | FALSE |
38 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C17orf65 | 0.03 | 0.01 | lasso | 10 | 0.02 | 3.6e-03 | 4.04 | -5.9 | 4.0e-09 | -0.64 | 0.05 | 0.78 | FALSE |
39 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | ASB16 | 0.02 | 0.03 | blup | 40 | 0.03 | 1.3e-04 | 7.29 | -7.3 | 3.2e-13 | -0.78 | 0.02 | 0.98 | FALSE |
40 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C17orf65 | 0.05 | 0.05 | lasso | 2 | 0.05 | 2.5e-06 | 6.59 | -6.8 | 9.5e-12 | -0.72 | 0.03 | 0.97 | FALSE |
41 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ASB16 | 0.03 | 0.03 | lasso | 3 | 0.03 | 3.2e-04 | 7.25 | -7.2 | 4.4e-13 | -0.76 | 0.02 | 0.96 | FALSE |
42 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C17orf65 | 0.04 | 0.04 | blup | 37 | 0.03 | 1.4e-04 | 7.23 | -7.3 | 3.5e-13 | -0.77 | 0.02 | 0.98 | FALSE |
43 | The Cancer Genome Atlas | Lung Adenocarcinoma | ASB16 | 0.02 | 0.02 | lasso | 4 | 0.01 | 6.3e-03 | 7.26 | -7.2 | 8.3e-13 | -0.77 | 0.02 | 0.82 | FALSE |
44 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | ASB16 | 0.04 | 0.04 | lasso | 4 | 0.03 | 1.8e-04 | 6.91 | -7.0 | 1.8e-12 | -0.75 | 0.02 | 0.96 | FALSE |
45 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C17orf65 | 0.07 | 0.05 | lasso | 6 | 0.05 | 3.1e-06 | 7.18 | -6.6 | 4.0e-11 | -0.77 | 0.02 | 0.98 | FALSE |
46 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C17orf65 | 0.04 | 0.03 | blup | 39 | 0.03 | 2.7e-03 | 7.19 | -7.4 | 1.8e-13 | -0.78 | 0.02 | 0.84 | FALSE |
47 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C17orf65 | 0.09 | 0.02 | blup | 38 | 0.04 | 8.0e-03 | 7.23 | -6.9 | 5.7e-12 | -0.77 | 0.01 | 0.52 | FALSE |
48 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | C17orf65 | 0.09 | 0.09 | enet | 8 | 0.08 | 2.9e-04 | 7.07 | -7.3 | 2.3e-13 | -0.79 | 0.02 | 0.95 | FALSE |
49 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | C17orf65 | 0.15 | 0.05 | blup | 37 | 0.09 | 1.7e-03 | 7.23 | -7.2 | 7.3e-13 | -0.74 | 0.02 | 0.70 | FALSE |
50 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | C17orf65 | 0.07 | 0.02 | blup | 38 | 0.04 | 1.1e-02 | 7.25 | -6.7 | 2.4e-11 | -0.73 | 0.01 | 0.55 | FALSE |
51 | The Cancer Genome Atlas | Thyroid Carcinoma | ASB16 | 0.07 | 0.01 | blup | 39 | 0.02 | 1.6e-03 | 7.18 | -6.5 | 7.7e-11 | -0.63 | 0.02 | 0.79 | FALSE |
52 | The Cancer Genome Atlas | Thyroid Carcinoma | C17orf65 | 0.03 | 0.03 | lasso | 7 | 0.03 | 3.8e-04 | 7.23 | -7.3 | 2.6e-13 | -0.79 | 0.02 | 0.95 | FALSE |